; and (2) deny any license required for the export, reexport, or in-country transfer to or in a covered country of any such technology, unless the person seeking the license submits to the Committee such documentation as the Secretary of State may reasonably require to demonstrate by clear and convincing evidence that, if the license is approved, the technology will not be used for human rights abuses or by an entity that has engaged in human rights abuses. (b) Technology described Technology described in this subsection is technology identified by the Secretary of Defense or the Secretary of State, in consultation with the Secretary of Health and Human Services, or the Secretary of Energy as genetic instruments, including— (1) Next Generation and Sanger Generation genetic sequencers; (2) genetic sequencing kits and reagents; (3) genetic testing and sampling kits (including forensic DNA testing kits); (4) related laboratory instruments; (5) any instrument-specific software— (A) relating to genetic testing, genetic mapping, genetic sequencing, genetic analysis and editing, or any technology described in any of paragraphs (1) through (4); and (B) included, on the day before the date of the enactment of this Act, under the definition of crime control and detection instruments under section 742.7 of the Export Administration Regulations; or (6) any other related genetic technology that could enable human rights abuses, as identified by the head of any agency represented on the End-User Review Committee, in consultation with the Secretary of Health and Human Services. (c) End-User Review Committee defined In this section, the term End-User Review Committee means— (1) the End-User Review Committee established under section 744.16(d) of title 15, Code of Federal Regulations